Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Biohaven Pharmaceutical Holding Co stock

Learn how to easily invest in Biohaven Pharmaceutical Holding Co stock.

Biohaven Pharmaceutical Holding Co is a biotechnology business based in the US. Biohaven Pharmaceutical Holding Co shares (BHVN) are listed on the NYSE and all prices are listed in US Dollars.

How to buy Biohaven Pharmaceutical Holding Co stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – BHVN. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance



  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Biohaven Pharmaceutical Holding Co stock price (NYSE: BHVN)

Use our graph to track the performance of BHVN stocks over time.

Biohaven Pharmaceutical Holding Co shares at a glance

Information last updated 2023-01-26.
Latest market close$18.81
52-week range$5.54 - $20.00
50-day moving average $15.48
200-day moving average $14.08
Wall St. target price$24.20
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-11.85

Buy Biohaven Pharmaceutical Holding Co stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Biohaven Pharmaceutical Holding Co stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biohaven Pharmaceutical Holding Co price performance over time

Historical closes compared with the close of $18.81 from 2023-01-27

1 week (2023-01-20) 2.01%
1 month (2022-12-29) 30.90%
3 months (2022-10-28) 22.70%
6 months (2022-07-29) -87.12%
1 year (2022-01-28) -85.26%
2 years (2021-01-29) -77.93%
3 years (2020-01-29) 50.9
5 years (2018-01-25) N/A

Biohaven Pharmaceutical Holding Co financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $1.47
Market capitalisation $1.3 billion

TTM: trailing 12 months

Biohaven Pharmaceutical Holding Co share dividends

We're not expecting Biohaven Pharmaceutical Holding Co to pay a dividend over the next 12 months.

Biohaven Pharmaceutical Holding Co overview

Biohaven Ltd. , a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. The company's pipeline products include BHV-7000, a potassium channel activator for the treatment of focal epilepsy; Troriluzole, a tripeptide prodrug that is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500, a low-trapping glutamate N-methyl-D-aspartate receptor antagonist for neuropathic pain; and Verdiperstat, an irreversible myeloperoxidase enzyme inhibitor for the treatment of neurodegenerative diseases. It also offers Taldefgrobep Alfa, an anti-myostatin adnectin, which is in Phase 3 clinical trial to treat spinal muscle atrophy; and BHV-1100 that is in Phase 1a/1b clinical trial for multiple myeloma patients. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in Sept 2022. The company was incorporated in 2022 and is headquartered in New Haven, Connecticut.

Frequently asked questions

What percentage of Biohaven Pharmaceutical Holding Co is owned by insiders or institutions?
Currently 14.669% of Biohaven Pharmaceutical Holding Co shares are held by insiders and 38.134% by institutions.
When does the fiscal year end for Biohaven Pharmaceutical Holding Co?
Biohaven Pharmaceutical Holding Co's fiscal year ends in December.
Where is Biohaven Pharmaceutical Holding Co based?
Biohaven Pharmaceutical Holding Co's address is: 215 Church Street, New Haven, CT, United States, 06510

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site